asciminib
novartis
['leusm', 'asciminib', '#mpn', 'mpnsm', 'cml']
#asco22 #mpnsm #leusm cortez: extremely uncommon to develop heme tox after first 6mo of therapy. the durable responses and good tolerability make asciminib an important development in cml. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)